Farr Barry M
Department of Medicine, University of Virginia Health System, Charlottesville, VA 22908, USA.
Infect Control Hosp Epidemiol. 2006 Oct;27(10):1096-106. doi: 10.1086/508759. Epub 2006 Sep 18.
The incidence of methicillin-resistant Staphylococcus aureus (MRSA) and vancomycin-resistant Enterococcus (VRE) infections continues to rise in National Nosocomial Infections Surveillance system hospitals, and these pathogens are reportedly causing more than 100,000 infections and many deaths each year in US healthcare facilities. This has led some to insist that control measures are now urgently needed, but several recent articles have suggested that isolation of patients does not work, is not needed, or is unsafe, or that a single cluster-randomized trial could be used to decide such matters. At least 101 studies have reported controlling MRSA infection and 38 have reported controlling VRE infection by means of active detection by surveillance culture and use of isolation for all colonized patients in healthcare settings where the pathogens are epidemic or endemic, in academic and nonacademic hospitals, and in acute care, intensive care, and long-term care settings. MRSA colonization and infection have been controlled to exceedingly low levels in multiple nations and in the state of Western Australia for decades by use of active detection and isolation. Studies suggesting problems with using such data to control MRSA colonization and infection have their own problems, which are discussed. Randomized trials are epidemiologic tools that can sometimes provide erroneous results, and they have not been considered necessary for studying isolation before it is used to control other important infections, such as tuberculosis, smallpox, and severe acute respiratory syndrome. No single epidemiologic study should be considered definitive. One should always weigh all available evidence. Infection with antibiotic-resistant pathogens such as MRSA and VRE is controllable to a low level by active detection and isolation of colonized and infected patients. Effective measures should be used to minimize the morbidity and mortality attributable to these largely preventable infections.
在国家医院感染监测系统所涵盖的医院中,耐甲氧西林金黄色葡萄球菌(MRSA)感染和耐万古霉素肠球菌(VRE)感染的发生率持续上升。据报道,在美国医疗机构中,这些病原体每年导致超过10万例感染以及许多死亡病例。这使得一些人坚持认为现在迫切需要采取控制措施,但最近的几篇文章表明,对患者进行隔离不起作用、没有必要或不安全,或者认为可以通过一项整群随机试验来决定此类问题。至少有101项研究报告了通过监测培养进行主动检测并对医疗机构中所有定植病原体的患者进行隔离,从而控制MRSA感染,还有38项研究报告了对VRE感染的控制情况,这些医疗机构包括病原体呈流行或地方性流行的学术和非学术医院,以及急性护理、重症监护和长期护理机构。几十年来,通过主动检测和隔离,多个国家以及西澳大利亚州已将MRSA定植和感染控制到极低水平。那些认为使用此类数据控制MRSA定植和感染存在问题的研究本身也存在问题,本文对此进行了讨论。随机试验是一种流行病学工具,有时可能会得出错误结果,而且在研究隔离措施用于控制其他重要感染(如结核病、天花和严重急性呼吸综合征)之前,人们并未认为有必要进行随机试验。任何一项流行病学研究都不应被视为定论。人们应该始终权衡所有可得证据。通过对定植和感染患者进行主动检测和隔离,耐抗生素病原体(如MRSA和VRE)感染可控制在较低水平。应采取有效措施,将这些在很大程度上可预防的感染所导致的发病率和死亡率降至最低。